US state pharmacists challenge drug plan

10 January 2001

The US state of Washington's new AWARDS program, which would give stateseniors drug discounts in return for a yearly fee of $15, may be put on hold by lawsuits brought by a group representing state pharmacists. One suit challenges the rules' legality and another seeks a stay in implementing the program until its legal status is determined.

The druggists say the program, which would give seniors 12%-30% discounts at some drugstores and 20%-49% discounts through mail order, would damage pharmacists' economic viability statewide, say Associated Press reports. Mail-order discounts would be negotiated with Merck-Medco, but local pharmacies need to buy medications at the usual price and absorb the discount.

The lawsuit was condemned by Washington Governor Gary Locke, who told the AP that as many as 275,000 people aged 55 and older could eventually benefit from the program, and that over 2,700 people had already expressed interest in applying for it.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight